Empery Asset Management, L.P. is an investment fund managing more than $9.46 million ran by Ryan Lane. There are currently 7 companies in Mr. Lane’s portfolio. The largest investments include Meta Materials Inc and Sellas Life Sciences Group I, together worth $6.57 million.
As of 5th August 2022, Empery Asset Management, L.P.’s top holding is 4,370,568 shares of Meta Materials Inc currently worth over $4.5 million and making up 47.6% of the portfolio value.
In addition, the fund holds 927,984 shares of Sellas Life Sciences Group I worth $2.07 million.
The third-largest holding is 89bio Inc worth $1.29 million and the next is Surrozen Inc worth $773 thousand, with 257,766 shares owned.
Currently, Empery Asset Management, L.P.'s portfolio is worth at least $9.46 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Empery Asset Management, L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Ryan Lane serves as the Chief Operating Officer at Empery Asset Management, L.P..
In the most recent 13F filing, Empery Asset Management, L.P. revealed that it had opened a new position in
Meta Materials Inc and bought 4,370,568 shares worth $4.5 million.
On the other hand, there are companies that Empery Asset Management, L.P. is getting rid of from its portfolio.
Empery Asset Management, L.P. closed its position in Sunshine Biopharma Inc on 12th August 2022.
It sold the previously owned 450,450 shares for $1.1 million.
Ryan Lane also disclosed a decreased stake in Surrozen Inc by 0.2%.
This leaves the value of the investment at $773 thousand and 257,766 shares.
The two most similar investment funds to Empery Asset Management, L.P. are William A. Ackman and Tokio Marine & Nichido Fire Insurance Co., Ltd. They manage $9.52 million and $9.66 million respectively.
Empery Asset Management, L.P.’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Health Care — making up 20.4% of
the total portfolio value.
The fund focuses on investments in the United States as
42.9% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
43% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $49.7 million.
These positions were updated on August 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Meta Materials Inc |
Opened
4,370,568
|
$4,502,000 | 47.58% |
| Sellas Life Sciences Group I |
Opened
927,984
|
$2,069,000 | 21.87% |
| 89bio Inc |
Opened
400,000
|
$1,288,000 | 13.61% |
| Sunshine Biopharma Inc |
Closed
450,450
|
$1,104,000 | |
| Surrozen Inc |
22.82%
257,766
|
$773,000 | 8.17% |
| The Valens Company Inc |
Closed
400,000
|
$688,000 | |
| Nisun Intl Ent Dvpmt Gp Co L |
Closed
672,556
|
$658,000 | |
| Applied Therapeutics, Inc. |
Opened
675,000
|
$640,000 | 6.76% |
| The Oncology Institute Inc |
Closed
70,733
|
$504,000 | |
| Soleno Therapetucs Inc |
Closed
1,401,400
|
$313,000 | |
| Calithera Biosciences Inc |
Closed
775,925
|
$313,000 | |
| Saverone 2014 Ltd |
Opened
51,036
|
$118,000 | 1.25% |
| Applied Genetic Technologies Corp |
Closed
100,000
|
$107,000 | |
| Statera Biopharma Inc |
Closed
333,016
|
$105,000 | |
| Imperial Pete Inc |
Closed
57,500
|
$83,000 | |
| Reeds Inc |
67.40%
456,469
|
$71,000 | 0.75% |
| InMed Pharmaceuticals Inc. |
Closed
61,741
|
$58,000 | |
| Rafael Holdings Inc |
Closed
11,983
|
$30,000 | |
| No transactions found | |||
| Showing first 500 out of 18 holdings | |||